Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) stimulate hyperglycemia-induced insulin secretion, decrease glucagon secretion, inhibit the hunger center, and delay gastric emptying, preventing large post-meal glycemic increments and reducing calorie intake and body weight (Nauck et al., 2021). This evidence concerns the gene GLP1R and Hyperglycemia.